South Korea Thrombophilia Testing Market was valued at USD 0.10 Billion in 2022 and is projected to reach USD 0.18 Billion by 2030, growing at a CAGR of 7.4% from 2024 to 2030.
The South Korea thrombophilia testing market is experiencing significant growth, driven by an increasing awareness of genetic disorders and the rising demand for advanced diagnostic methods. Thrombophilia, a condition that increases the risk of blood clots, is often underdiagnosed due to its complex nature and subtle symptoms. However, with technological advancements and the growing number of individuals experiencing thrombotic events, the need for reliable thrombophilia testing has surged across South Korea's healthcare landscape.
One of the key drivers of the thrombophilia testing market in South Korea is the increasing prevalence of risk factors such as obesity, aging populations, and lifestyle-related diseases. Medical professionals and diagnostic laboratories in South Korea are leveraging state-of-the-art technologies to detect genetic mutations and other biomarkers associated with thrombophilia. This is in response to the rise in deep vein thrombosis (DVT) and pulmonary embolism (PE), two life-threatening complications linked to the disorder.
Thrombophilia testing typically includes genetic testing for mutations like Factor V Leiden and Prothrombin gene mutation, as well as screening for antiphospholipid syndrome. The South Korean healthcare industry requires a diverse range of testing options, from basic to comprehensive panels, which can detect multiple risk factors simultaneously. This growing requirement has led to the increased adoption of advanced molecular diagnostic tools and testing kits, benefiting both patients and healthcare providers alike.
Industries, including pharmaceuticals, biotechnology, and healthcare providers, are significantly contributing to the growth of the thrombophilia testing market in South Korea. The pharmaceutical industry is particularly focused on developing innovative anticoagulant therapies for patients with thrombophilia. Meanwhile, clinical laboratories and hospitals are investing in advanced diagnostic equipment and infrastructure to meet the rising demand for accurate and quick thrombophilia tests.
Additionally, the trend toward personalized medicine is further driving the need for tailored thrombophilia testing. Healthcare providers are seeking more efficient testing methods that allow them to create customized treatment plans based on individual genetic profiles. This shift towards precision medicine is expected to continue to shape the future of the thrombophilia testing market in South Korea.
Get an In-Depth Research Analysis of the South Korea Thrombophilia Testing Market Size And Forecast [2025-2032]
Â
Siemens
LabCorp
Instrumentation Laboratory SpA
Johns Hopkins Medicine
Abbott
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Thrombophilia Testing Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Thrombophilia Testing Market
Genetic Testing
Acquired Testing
Functional Testing
Serological Testing
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Recurrent Miscarriages
Unexplained Thromboembolism
Hospitals
Diagnostic Laboratories
Research Institutions
Specialized Clinics
In-Lab Testing
Point-of-Care Testing
At-Home Testing Kits
Reagents and Kits
Instruments
Software and Services
Consumables
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Thrombophilia Testing Market Research Analysis
1. Introduction of the South Korea Thrombophilia Testing Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Thrombophilia Testing Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Thrombophilia Testing Market, By Type
6. South Korea Thrombophilia Testing Market, By Application
7. South Korea Thrombophilia Testing Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Thrombophilia Testing Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/